The differences in NCL expression were statistically significant between neuroblastoma and pre-B ALL (p = 0.003), between neuroblastoma and the controls (p < 0.001), and borderline significant between pre-B ALL and the controls (p = 0.051). Here, NUCLEOLIN is linked to acute lymphoblastic leukemia.